BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 43 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,168,000 | +6.9% | 986,000 | -0.7% | 0.00% | -100.0% |
| Q1 2018 | $1,093,000 | -66.3% | 993,000 | -63.3% | 0.00% | -50.0% |
| Q3 2017 | $3,242,000 | +209.1% | 2,709,000 | +207.1% | 0.00% | +100.0% |
| Q2 2017 | $1,049,000 | -79.7% | 882,000 | -79.8% | 0.00% | -75.0% |
| Q1 2017 | $5,161,000 | +154.1% | 4,372,000 | +152.1% | 0.00% | +100.0% |
| Q4 2016 | $2,031,000 | -63.4% | 1,734,000 | -61.0% | 0.00% | -50.0% |
| Q3 2016 | $5,547,000 | +1359.7% | 4,450,000 | +1252.6% | 0.00% | – |
| Q2 2016 | $380,000 | -86.6% | 329,000 | -86.2% | 0.00% | -100.0% |
| Q1 2016 | $2,833,000 | +2148.4% | 2,390,000 | +2415.8% | 0.00% | – |
| Q4 2015 | $126,000 | -96.5% | 95,000 | -96.5% | 0.00% | -100.0% |
| Q3 2015 | $3,607,000 | +2273.0% | 2,685,000 | +2696.9% | 0.00% | – |
| Q2 2015 | $152,000 | +11.8% | 96,000 | +6.7% | 0.00% | – |
| Q1 2015 | $136,000 | +23.6% | 90,000 | 0.0% | 0.00% | – |
| Q4 2014 | $110,000 | -16.0% | 90,000 | -25.0% | 0.00% | – |
| Q3 2014 | $131,000 | -68.1% | 120,000 | -69.3% | 0.00% | – |
| Q2 2014 | $411,000 | +85.1% | 391,000 | +95.5% | 0.00% | – |
| Q1 2014 | $222,000 | +29.8% | 200,000 | +23.5% | 0.00% | – |
| Q4 2013 | $171,000 | – | 162,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 6,195,000 | $9,377,000 | 2.84% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $10,750,000 | 1.09% |
| Man Investments (CH) AG | 1,100,000 | $1,482,000 | 0.73% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 22,554,000 | $30,444,000 | 0.47% |
| SSI INVESTMENT MANAGEMENT LLC | 3,124,000 | $4,202,000 | 0.45% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 20,000 | $22,373,000 | 0.42% |
| Calamos Advisors LLC | 35,219,000 | $47,628,000 | 0.33% |
| LINDEN ADVISORS LP | 2,500,000 | $3,370,000 | 0.23% |
| Calamos Wealth Management LLC | 513,000 | $694,000 | 0.17% |
| LOOMIS SAYLES & CO L P | 477,810 | $50,323,000 | 0.15% |